- Trials with a EudraCT protocol (23)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
23 result(s) found for: Insemination.
Displaying page 1 of 2.
EudraCT Number: 2006-003481-34 | Sponsor Protocol Number: indvFSH2006 | Start Date*: 2006-08-04 |
Sponsor Name:Fertilitetsklinikken 4071, Rigshospitalet | ||
Full Title: Individuel versus standard rFSH dosis til kontrolleret ovariel stimulation og intrauterin insemination Et prospektivt randomiseret multicenter studie | ||
Medical condition: Ovulatory women suffering from infertility | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001034-18 | Sponsor Protocol Number: NL43131-018-13 | Start Date*: 2013-09-05 | |||||||||||
Sponsor Name:AMC Amsterdam | |||||||||||||
Full Title: Super ovulation in intrauterine insemination: FSH or Clomifene citrate | |||||||||||||
Medical condition: Women diagnosed with unexplained subfertility or mild male factor subfertility with an indication for intra uterine insemination | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002321-11 | Sponsor Protocol Number: 2016LAT | Start Date*: 2016-12-27 | |||||||||||
Sponsor Name:Helena Tinkanen, Tampereen yliopistollinen sairaala | |||||||||||||
Full Title: Scientific title: A Protocol for a Randomized, Controlled Study to Compare the Use of Gonodotropin-releasing Hormone Agonist Triptoreline (Gonapeptyl®) for Luteal Phase Support Versus Natural Lutea... | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002135-30 | Sponsor Protocol Number: NCT04379973 | Start Date*: 2021-04-28 |
Sponsor Name:Antwerp University Hospital (UZA) | ||
Full Title: Live birth after additional tubal flushing with oil-based contrast versus no additional flushing: a randomised, multicentre, parallel group pragmatic trial in infertile women with at least one pate... | ||
Medical condition: Infertility defined as lack of conception despite 12 months of unprotected intercourse, or three cycles of donor insemination without pregnancy or three ovulatory ovulation induction cycles without... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023867-17 | Sponsor Protocol Number: S52775 | Start Date*: 2011-03-25 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Impact of luteal phase support with vaginal progesterone on the clinical pregnancy rate in IUI cycles stimulated with gonadotrophins: a prospective randomized multicentre study. | ||||||||||||||||||
Medical condition: Subfertility | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-004153-24 | Sponsor Protocol Number: NL62838.029.18 | Start Date*: 2019-07-30 |
Sponsor Name:Amsterdam UMC - location Vrije Universiteit Amsterdam | ||
Full Title: Tubal flushing with oil-based contrast during HSG in subfertile women: Is early flushing effective and cost-effective as compared to delayed flushing? | ||
Medical condition: The research population consists of infertile women aged between 18 and 39 years of age, who have a spontaneous menstrual cycle and with a perceived low risk for tubal pathology, undergoing fertili... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004192-12 | Sponsor Protocol Number: NL66079.029.18 | Start Date*: 2019-08-05 |
Sponsor Name:Amsterdam UMC, location VU medical Center | ||
Full Title: Oil- based versus water-based contrast media for hysterosalpingography (HSG) in infertile women with unevaluated indications: a randomized controlled trial | ||
Medical condition: The research population consists of infertile couples who have tried to conceive for at least 12 months, or have oligo- or anovulation. We will focus on women with ovulation disorders, or at high r... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002547-83 | Sponsor Protocol Number: 2006-05 | Start Date*: 2007-02-15 |
Sponsor Name:Dr. Peter Sydow | ||
Full Title: GnRH-Agonisten-Therapie bei Frauen mit Endometriose der Stadien III-IV nach rASRM-Kriterien vor reproduktionsmedizinischen Techniken (IVF / ICSI) (GARTE-Studie) | ||
Medical condition: Women with endometriosis who have been diagnosed with Stages III -IV according to rASRM criteria | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004604-20 | Sponsor Protocol Number: AGO/2018/007 | Start Date*: 2019-12-03 |
Sponsor Name:Ghent University Hospital | ||
Full Title: Myo-inositol versus clomiphene citrate as first line treatment for ovulation induction in PCOS | ||
Medical condition: Polycystic ovary syndrome (PCOS) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-005420-42 | Sponsor Protocol Number: S55983 | Start Date*: 2014-02-06 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Is postoperative IUI better than expectant management in infertile endometriosis patients with good prognosis based on EFI score? | ||||||||||||||||||
Medical condition: (Sub)Fertility in endometriosis after laparoscopic removal of the endometriosos lesions: an RCT comparing intra-uterine insemination with expectant management | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003874-17 | Sponsor Protocol Number: PrEPC/INMI | Start Date*: 2014-12-22 | |||||||||||
Sponsor Name:National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS | |||||||||||||
Full Title: Antiretroviral Pre-exposure prophylaxis for natural conception (PrEP-C) in serodiscordant female partners of HIV-infected men in sustained virologic suppression | |||||||||||||
Medical condition: Prophylaxis against HIV infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003451-42 | Sponsor Protocol Number: 19642021 | Start Date*: 2021-12-23 | |||||||||||
Sponsor Name:Dept. of Growth and Reproduction | |||||||||||||
Full Title: FITMI - First In Treating Male Infertility | |||||||||||||
Medical condition: Male infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000941-42 | Sponsor Protocol Number: FSD-IEQ-2021-03 | Start Date*: 2021-07-06 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Fundacion Santiago Dexeus Font | ||||||||||||||||||||||||||||||||||||||
Full Title: The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial. | ||||||||||||||||||||||||||||||||||||||
Medical condition: To compare the number of GQB and the morphokinetic parameters of early embryo development in infertile suboptimal patients undergoing two different intensities of ovarian stimulation, a milder appr... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002823-34 | Sponsor Protocol Number: 27818 | Start Date*: 2007-11-08 | |||||||||||
Sponsor Name:Merck Serono International S.A | |||||||||||||
Full Title: A phase II, multicentre, randomised, assessor.blinded, active-comparator, parallel-group dose finding trial to evaluate AS900672-Enriched versus follitropin alfa (GONAL-f) in oligo-anovulatory infe... | |||||||||||||
Medical condition: oligoanovulatory infertile women who are candidates for ovulation induction (OI) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) FR (Completed) DE (Prematurely Ended) IT (Prematurely Ended) ES (Completed) DK (Completed) BE (Completed) NL (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023534-23 | Sponsor Protocol Number: EMR 200061-504 | Start Date*: 2011-05-09 | ||||||||||||||||
Sponsor Name:Merck Serono S.A. - Geneva | ||||||||||||||||||
Full Title: A phase IIIB, multicentre, multinational, randomized, open-label trial to compare the efficacy and safety of ovarian stimulation with GONAL-f® day 1 to day 5 followed by Pergoveris® starting day 6 ... | ||||||||||||||||||
Medical condition: Fertility disorders | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: NL (Completed) SK (Completed) DE (Completed) FI (Completed) GB (Completed) DK (Completed) GR (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-003779-31 | Sponsor Protocol Number: BER-FSH-2015-01 | Start Date*: 2015-12-04 | |||||||||||
Sponsor Name:INSTITUTO BERNABEU | |||||||||||||
Full Title: Prospective, Randomized Open Trial to Evaluate the Efficacy of Highly Purified Urinary FSH (Fostipur®, IBSA) versus Recombinant FSH (Bemfola® Finox) in Oocyte Donors Undergoing Controlled Ovarian S... | |||||||||||||
Medical condition: Ovarian stimulation for oocyte donation. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001726-22 | Sponsor Protocol Number: COLIGROW | Start Date*: 2022-12-12 | |||||||||||
Sponsor Name:Dr. Ignacio Herraiz García | |||||||||||||
Full Title: COok's ballon versus dinoprostone for Labor Induction of term pregnancies with fetal GROWth restriction (COLIGROW study). | |||||||||||||
Medical condition: Induction of term pregnancies with fetal growth restriction. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002571-25 | Sponsor Protocol Number: 2017.corifollitropinalfa_IVM | Start Date*: 2017-10-18 | |||||||||||
Sponsor Name:UZ Brussel | |||||||||||||
Full Title: A comparison between corifollitropin alfa and recombinant FSH for follicular recruitment in women with polycystic ovaries who undergo IVM treatment | |||||||||||||
Medical condition: Infertile patients with polycystic ovaries | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001616-30 | Sponsor Protocol Number: 000071 | Start Date*: 2013-09-17 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A controlled, assessor-blind, parallel groups, multicentre, multinational trial evaluating the immunogenicity of FE 999049 in repeated cycles of controlled ovarian stimulation in women undergoing a... | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) CZ (Completed) DK (Completed) ES (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001669-17 | Sponsor Protocol Number: 000004 | Start Date*: 2013-09-17 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the efficacy and safety of FE 999049 with follitropin alfa (GONAL-F) in controlled ovarian stim... | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) CZ (Completed) DK (Completed) PL (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
